152 related articles for article (PubMed ID: 36268549)
61. Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort.
Liang N; Sun M; Sun R; Xu T; Cui L; Wang C; Ma L; Cheng X; Xue X; Sun W; Yuan X; Zhang H; Li H; He Y; Ji A; Wu X; Li C
Arthritis Res Ther; 2019 Sep; 21(1):200. PubMed ID: 31477161
[TBL] [Abstract][Full Text] [Related]
62. Ultrasonography in the diagnosis of asymptomatic hyperuricemia and gout.
Puig JG; Beltrán LM; Mejía-Chew C; Tevar D; Torres RJ
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):517-523. PubMed ID: 27906639
[TBL] [Abstract][Full Text] [Related]
63. Relationship between structural joint damage and urate deposition in gout: a plain radiography and dual-energy CT study.
Dalbeth N; Aati O; Kalluru R; Gamble GD; Horne A; Doyle AJ; McQueen FM
Ann Rheum Dis; 2015 Jun; 74(6):1030-6. PubMed ID: 24521739
[TBL] [Abstract][Full Text] [Related]
64. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?
Ruoff G; Edwards NL
Postgrad Med; 2016 Sep; 128(7):706-15. PubMed ID: 27558643
[TBL] [Abstract][Full Text] [Related]
65. Ultrasound and clinical features of hip involvement in patients with gout.
Di Matteo A; Filippucci E; Cipolletta E; Musca A; Di Donato E; Martire V; Jesus D; Salaffi F; Grassi W
Joint Bone Spine; 2019 Oct; 86(5):633-636. PubMed ID: 30779966
[TBL] [Abstract][Full Text] [Related]
66. The clinical efficacy of urate-lowering therapy in acute gout: a meta-analysis of randomized controlled trials.
Zhang X; Tang Y; Wang M; Wang D; Li Q
Clin Rheumatol; 2021 Feb; 40(2):701-710. PubMed ID: 32562072
[TBL] [Abstract][Full Text] [Related]
67. Ultrasonography for diagnosing atypical gout. Two case reports.
Le Goff B; Berthelot JM; André V; Guillot P; Maugars Y
Joint Bone Spine; 2008 Oct; 75(5):610-2. PubMed ID: 18674948
[TBL] [Abstract][Full Text] [Related]
68. Diagnosis of gout.
Schlesinger N
Minerva Med; 2007 Dec; 98(6):759-67. PubMed ID: 18299687
[TBL] [Abstract][Full Text] [Related]
69. Ultrasound learning curve in gout: a disease-oriented training program.
Gutiérrez M; Di Geso L; Rovisco J; Di Carlo M; Ariani A; Filippucci E; Grassi W
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1265-74. PubMed ID: 23509029
[TBL] [Abstract][Full Text] [Related]
70. 2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Neogi T; Jansen TL; Dalbeth N; Fransen J; Schumacher HR; Berendsen D; Brown M; Choi H; Edwards NL; Janssens HJ; Lioté F; Naden RP; Nuki G; Ogdie A; Perez-Ruiz F; Saag K; Singh JA; Sundy JS; Tausche AK; Vazquez-Mellado J; Yarows SA; Taylor WJ
Arthritis Rheumatol; 2015 Oct; 67(10):2557-68. PubMed ID: 26352873
[TBL] [Abstract][Full Text] [Related]
71. Achievement of the target serum urate level among patients with gout treated with allopurinol or febuxostat in an arthritis clinic in the Philippines.
Quilisadio JEC; Salido EO; Penserga EG
Mod Rheumatol; 2021 May; 31(3):755-761. PubMed ID: 32701037
[TBL] [Abstract][Full Text] [Related]
72. Are ultrasound features at the first metatarsophalangeal joint associated with clinically-assessed pain and function? A study of people with gout, asymptomatic hyperuricaemia and normouricaemia.
Stewart S; Dalbeth N; Vandal AC; Allen B; Miranda R; Rome K
J Foot Ankle Res; 2017; 10():22. PubMed ID: 28539973
[TBL] [Abstract][Full Text] [Related]
73. Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.
Beslon V; Moreau P; Maruani A; Maisonneuve H; Giraudeau B; Fournier JP
J Gen Intern Med; 2018 Mar; 33(3):358-366. PubMed ID: 29204974
[TBL] [Abstract][Full Text] [Related]
74. Role of ultrasound and other advanced imaging in the diagnosis and management of gout.
Thiele RG
Curr Rheumatol Rep; 2011 Apr; 13(2):146-53. PubMed ID: 21210257
[TBL] [Abstract][Full Text] [Related]
75. Update on the diagnosis and management of gout.
Ting K; Graf SW; Whittle SL
Med J Aust; 2015 Jul; 203(2):86-8. PubMed ID: 26175247
[TBL] [Abstract][Full Text] [Related]
76. Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
Baraf HS; Becker MA; Gutierrez-Urena SR; Treadwell EL; Vazquez-Mellado J; Rehrig CD; Ottery FD; Sundy JS; Yood RA
Arthritis Res Ther; 2013 Sep; 15(5):R137. PubMed ID: 24286509
[TBL] [Abstract][Full Text] [Related]
77. Urate-lowering therapy (ULT) reduces non-episodic foot pain in patients who fail to meet ACR/EULAR 2015 gout classification criteria: an effect predicted by ultrasound and potential rationale for reclassification.
Alammari YM; Gheta D; Flood RM; Boran G; Kane DJ; Mullan RH
Ann Rheum Dis; 2019 Apr; 78(4):579-580. PubMed ID: 30373883
[No Abstract] [Full Text] [Related]
78. Diagnostic value of ultrasound versus dual-energy computed tomography in patients with different stages of acute gouty arthritis.
Zhang B; Yang M; Wang H
Clin Rheumatol; 2020 May; 39(5):1649-1653. PubMed ID: 32157468
[TBL] [Abstract][Full Text] [Related]
79. The gouty tophus: a review.
Chhana A; Dalbeth N
Curr Rheumatol Rep; 2015 Mar; 17(3):19. PubMed ID: 25761926
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
